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Introduction
Mesenchymal stem cells (MSC) are multipotent cells 
that can differentiate into different cell lines depending on 
the micromedium in which they are stored [1, 2, 3, 4, 5]. 
These cells had a wide utilization in researches for regenera-
tion of bone tissue, cartilaginous tissue, tendon, meniscus, 
degenerative lesions of the locomotor apparatus, nervous 
system and internal organs [6, 7, 8, 9, 10, 11, 12, 13]. Meth-
ods of bone marrow harvesting from laboratory animals for 
isolation and cultivation of MSC for in vivo and in vitro tests 
are diverse. Most common method of bone marrow extrac-
tions is slaughtering of the animals with further jet flush-
ing of diaphyses and epiphyses of long tubular bones [14, 
15]. However, this method allows to use obtained stem cells 
for in vitro tests and allogeneic transplantation for in vivo 
tests. Another way is the aspiration of bone marrow from 
the metaphyseal areas of the long tubular bones after perfo-
rating the bone with a drill bit [16, 17, 18]. It requires a deep 
anesthesia and a lot of time for the procedure. This method 
allows experiments on the animals with autocells, but the 
deep anesthesia, the surgery that certainly will not be the 
last and the postoperative recovery period may endanger 
the experiments success due to suffering or even death of 
the animal [19]. Another way is performing of a short-term 
superficial anesthesia with local potency and harvesting the 
bone marrow from the iliac bone [2, 3], a similar procedure 
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Abstract
Background: Bone marrow mesenchymal stem cells (MSC) have a wide application in domain of Regenerative Medicine. Of a great importance is utilization 
of a suitable bone marrow extraction technique that can provide a sufficient number of MSC to perform laboratory tests without seriously affecting the 
health of the laboratory animal. At the same time, before using in researches and clinical application, the MSC needs to be identified.
Material and methods: The study was conducted in rabbits (n = 9), in which, from one iliac bone,  by aspiration were taken 3.39 ± 1.27 ml of bone 
marrow. The nucleated bone marrow cells were separated through centrifugation using concentration gradient. The specific for stem cells culture medium 
was used, and MSC were multiplied during 2 passages. From the obtained MSC, 1x106 cells were subject to differentiation by chondrocytes lineage for 
other 20 days. The obtained chondrocytes aggregates were morphologically examined by Hematoxylin–Eosin staining and specific cartilage staining 
with Safranin O and Toluidine blue/fast green. 
Results: There was a strong correlation between the volume of collected bone marrow and the time required to achieve a 70-80% of MSC confluence 
(p=0.01). Also, the MSC isolated from bone marrow extracted from rabbit iliac bone were differentiated successful on chondrocyte line in all cases, 
confirmed through the specific cartilage staining with Safranin O and Toluidine blue/fast green (p<0,001).
Conclusions: The volume of  3.39 ± 1.27 ml of bone marrow, harvested from rabbit iliac bone is sufficient to obtain a large number of MSC for the 
laboratory tests in vitro and in vivo. As a standard method for MSC identification could be used just the capability of the cells to differentiate in the 
specialized cell, including chondrocytes.
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performed in humans [20]. A similar method is nucleated 
cells separation from iliac crest after resection [21], since 
this method involves extraction and shredding of a bone 
piece, followed by trypsin treatment, isolation only of MSC 
is compromised. It is a great risk that the culture can be 
contaminated with a large number of osteoblasts and fibro-
blasts, also the time needed for the procedure is bigger [22].
Material and methods
The study was performed on 9 house rabbits from 4 to 
5 months old, 6 females and 3 males, with average weight 
of 3.78 ± 0.25 kg, in which, from one iliac bone were tak-
en 3.39 ± 1.27 ml of bone marrow, followed by separation 
of nucleated cells with concentration gradient HiSep LSM 
1077 (HiMedia, India). Then, the cells were cultured with 
mesenchymal stem cell expansion medium HiMesoXL (Hi-
Media, India) in incubator at 37°C, 5%CO2 (SMART CELL, 
Heal Force) during the first 2 passages. In order to demon-
strate the presence of MSC in culture, the MSC from the 
2nd passage were differentiated into chondrocytes using the 
chondrocyte differentiation medium HiChondroXL (Hi-
Media, India). The differentiated chondrocyte aggregates 
were histologically examined by cartilage specific staining. 
The research on rabbits received a positive decision at the 
ethics committee meeting of 14.12.2016, No 31.
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Cell media preparation
Culture medium for MSC was obtained by adding 11.4 
ml of component B in 500 ml of component A of the me-
dium for the MSC expansion HiMesoXL (HiMedia, India) 
and 5 ml of antimycotic antibiotic solution (HiMedia, India) 
[23].
The medium for chondrocyte differentiation is obtained 
by adding component B to 100 ml of component A of the 
chondrocyte differentiation medium HiChondroXL (Hi-
Media, India) and 1 ml of antimycotic antibiotic solution 
(HiMedia, India) [24].
The medium was prepared according to the manufactur-
er’s instructions, with further sterilisation by filtration with 
0.22 μm pores diameter PES filters (Sofra, China) and stored 
in the refrigerator at 4-8°C.
Isolation and cultivation of MSC from bone marrow 
harvested from the iliac bone
On the day of bone marrow harvesting, the animals were 
not fed, after weighing, they were anesthetized by intramus-
cular injection of 5 mg/kg xylazine and 2 mg/kg diazepam 
solutions. With a trimmer, the fur was removed from the 
dorsal part of the basin followed by aseptic processing with 
betadine and 70% alcohol solution. To potentiate the anes-
thesia, at the level of the iliac wing were injected 4 ml of 1% 
lidocaine. Was prepared a 5 ml syringe with 1250-2000 U 
heparin. A 18 G needle with trocar was used to perforate 
the first cortical of the iliac bone at the level of iliac wing. 
After bone perforation, the trocar was extracted and the 
bone marrow was aspirated with the heparinized syringe [2, 
3] (fig. 1). The bone marrow went to laboratory for further 
processing and the animal was taken back to the vivarium.
Fig. 1.  Bone marrow harvesting from a rabbit iliac bone. 
Preparing the animal for bone marrow harvest (a), preparation 
of necessary tools for the procedure (b) and the harvested bone 
marrow in 5 ml syringe (c).
In the laboratory, the concentration gradient HiSep LSM 
1077 (HiMedia, India) and PBS (Lonza, Belgium) preven-
tively, were heated at 370C, in the water bath. In a 15 ml ster-
ile tube the concentration gradient was poured in an equal 
volume with harvested bone marrow. The bone marrow was 
shifted in a 10 or 20 ml syringe containing the same vol-
ume of PBS (Lonza, Belgium). After homogenization, the 
PBS with bone marrow have been poured cautiously on the 
concentration gradient from the 15 ml tube without mixing. 
The tube was centrifuged at 400 x g for 15 minutes followed 
by removal of upper 2/3 of platelets and adipocytes layer, 
the mononuclear cells layer was collected in a separate tube 
along with 1/3 of the remaining overlying layer and the up-
per 1/3 of concentration gradient layer [25]. Then the tube 
was filled with PBS, followed by a careful pipetting and cen-
trifuged at 170 x g for 10 minutes (fig. 2). The supernatant 
was removed and the centrifugation has been repeated after 
pipetting the cells with 10 ml of culture medium. After cen-
trifugation the cells were resuspended in 5 ml culture medi-
um, placed in a 25 cm2 cell culture flask (Nunc, Denmark). 
The cells were cultivated in the incubator (SMART CELL, 
Heal Force) at 37°C with 5% CO2, changing every 2-3 days 
of a half of the nutrition medium (fig. 3).
Fig. 2.  Processing of harvested bone marrow. The 15 ml 
tube with bone marrow mixed with PBS located upon the 
concentration gradient in a ratio of 1: 1: 1 (a), separation in 
layers after centrifugation (b) and the bone marrow nucleated 
cell layer separated in another tube (c).
After a 70–80% confluence, the attached cells were 
washed twice with PBS , followed by addition of 2 ml tryp-
sin–EDTA 0.25% solution into the flask. The flask was 
placed in the incubator for 3 to 5 minutes, after which 2–3 
coups were applied to the flask, followed by visualisation 
under phase contrast microscope to evaluate the detach-
ment of the cells. Trypsinization was stopped with 3 ml of 
soybean trypsin inhibitor (Lonza, Belgium). The cells sus-
pension was centrifuged at 170 x g for 5 minutes. After su-
pernatant decantation, 5 ml of culture medium were added 
and the cells gently pippeted. The cells were counted with 
haemocytometer and viability was assessed with 0.4% try-
pan blue (Sigma, UK). Then all cells were placed in 75 cm2 
cell culture flasks (Nunc, Denmark) at a density of 1x104 ± 
1x103 cells/cm2, with total culture medium change every 2 
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days, until a 80-90% confluence (fig. 4). After trypsinization 
and cells counting with trypan blue (Sigma, UK), from each 
culture have been isolated 1x106 cells and differentiated on 
chondrocytes lineage .The remained cells were frozen in 
concentration 5x105 cells/ml with 10% DMSO (OriGen Bio-
medical, Germany) for future use.
Chondrocyte differentiation from MSC
The MSC differentiation potential is considered to be 
a functionally reliable criteria for their identification and 
their distinction from preadipocytes, preosteocytes or pre-
chondrocytes [2, 23, 3]. Was used the chondrocytes line dif-
ferentiation medium HiChondroXL (HiMedia, India).
The tube was placed into the incubator with a gently 
opened lid at 37°C, 5% CO2, without disturbing the cell pel-
lets. The chondrocyte differentiation medium was changed 
every 48 hours for 20 days [17]. At the 5th–7th days of differ-
entiation, at the bottom was observed formation of spheri-
cal or oval shape aggregates (fig. 5). After 20 days the aggre-
gates were introduced into 10% buffered formaldehyde and 
stained with Hematoxylin–Eosin and specific staining for 
cartilage with Safranin O and Toluidine blue/fast green [26].
Fig. 5.  MSC differentiation on chondrocyte line in 15 ml 
polypropylene tubes. The aspect of 1x106 MSC before the 
differentiation on chondrocyte lineage (a) and chondrocytes 
aggregates (b).
In a 15 ml polypropylene tube were introduced 1x106 
cells/ml of MSC culture medium. The tube was centrifuged 
at 45 x g for 10 minutes, followed by supernatant elimination 
and addition of 1 ml of chondrocyte differentiation medium 
HiChondroXL (HiMedia, India).  The cells were gently re-
suspended in medium and the tube was centrifuged again. 
The tube was placed into the incubator with a gently opened 
lid at 37°C, 5% CO2, without disturbing the cell pellets. The 
chondrocyte differentiation medium was changed every 
48 hours for 20 days [17]. On the 5th–7th days of differen-
tiation, at the bottom was observed formation of spherical 
or oval shape aggregates (fig. 5). After 20 days the aggre-
gates were introduced into 10% buffered formaldehyde and 
stained with Hematoxylin–Eosin and specific staining for 
cartilage with Safranin O and Toluidine blue/fast green [26]. 
The statistical analysis of the obtained data was carried 
out using Excel and SPSS Statistics 17.0 programs.
Results
The time needed for bone marrow harvesting from the 
beginning of anesthesia is 36±3 minutes. During the bone 
marrow harvesting and after that, complications in experi-
mental animals were not recorded. Once the cells from the 
1st passage reached a 70–80% confluence they were trypsin-
ized, thus, the average duration of the first passage cultivation 
was 7±1 days with a strong correlation between the volume 
of harvested bone marrow and the number of days required 
to achieve a 70–80% cells confluency (p=0.01). In Table 1 are 
presented the results of the MSC obtained from rabbit bone 
marrow resulted from cultivation in the first 2 passages.
In all cases the 2nd passage was cultivated for 5 days, 
sufficient time to achieve a 80–90% cellular confluence in 
all cases. So the average duration of cells cultivation during 
the first 2 passages was 12 ± 1 days, with a surprisingly 100% 
cell viability in all cases.
Fig. 3.  Isolation of MSC from bone marrow. x60. Concentrate of bone marrow nucleated cells (a), appearance of fusiform cells attached 
to the cell culture flask bottom after 2 days  of cells culture (b) and the 70–80% confluence of the MSC after 5 days of culture (c).
Fig. 4.  MSC culture in the 2nd passage. x60. MSC attached to the culture surface with traces of bone marrow cells after 24 
hours of culture (a), CSM on the 3rd day of culture (b) and the 90% confluence of MSC at the 5th day of culture (c).
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In the process of chondrocyte differentiation, cells ag-
gregates were of irregular spherical shape attached to the 
bottom of the tube, which later detached and floated freely 
in the medium. Also in the first days of differentiation, the 
cells could be easily dispersed by pipetting, but after that 
they became floating aggregates, the cells were no more dis-
persed by pipetting. Though, the cells aggregates consisted 
of the same number of cells, they could have different sizes, 
which vary between 1.5 and 3 mm in diameter (fig. 5).
Table 1
MSC obtained from rabbit bone marrow resulted from 
cultivation in the first 2 passages
Rabbit 
body 
mass (kg)
Volume of 
harvested 
bone mar-
row (ml)
Proce-
dure 
duration 
(min)
The 1st 
passage 
cultivati-
on (days)
Number 
of cells 
from the 
1st pas-
sage
Number 
of cells 
from the 
2nd pas-
sage
3.2 4.5 40 6 775000 4250000
3.8 2.5 40 7 675000 3500000
3.6 4.0 35 6 750000 4200000
3.9 2.0 30 8 850000 4900000
3.2 1.5 35 8 800000 4550000
3.8 4.5 35 6 800000 4300000
3.6 5.0 35 5 725000 3800000
3.8 2.5 35 8 725000 4050000
3.9 4.0 40 6 625000 3500000
3.64±0.27 3.39±1.27 36±3 7±1
747222
±68970
4116667±
464354.4
At the histological examination with Hematoxylin–Eo-
sin, a rich cellularity of aggregates was determined, high-
lighted by a high density of cells and extracellular matrix 
formation (fig. 6).
At Toluidine blue/fast green staining, the obtained struc-
ture was intensely colored in purple and blue. As the cells 
are arranged in conglomerates, their nuclei can not be dis-
tinguished due to the overlapping of a large number of them, 
at the same time the blue color represents the cartilage extra-
cellular matrix synthesized by chondrocytes (fig. 7). 
Fig. 6.  Hematoxylin-Eosin staining of the chondrocytes aggregates. x80.
Fig. 7.  Toluidine blue staining and Fast Green of  formed aggregates. x80.
Fig. 8.  Safranin O staining of the cells agregates. x 80.
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After staining with Safranin O, a large number of dark-
ened nuclei were determined and the extracellular matrix 
secreted by the cells was stained in red, this being specific to 
cartilaginous tissue (fig. 8).
The identification of obtained cells aggregates was posi-
tive at the specific staining for cartilaginous tissue in all cas-
es (n=9) and is statistically significant (p<0.001).
Discussion
Bone marrow harvesting from rabbit iliac bone serves as 
an effective way to isolate and cultivate mesenchymal stem 
cells. This method allows performing in vivo tests with rabbit 
own MSC, without subjecting the animal to great suffering 
which could adversely affect the results of the experiments 
[19]. Numerous cases of MSC isolation from long tubular 
bones after rabbit sacrifice are described in the literature 
[14, 8, 15, 12], or aspiration of bone marrow from metaphy-
seal areas of long tubular bones, like femur or even tibia [16, 
17, 12, 18] and nucleated cells separation from iliac crest 
after resection [21]. 
The iliac bone is smaller than the femoral bone, 
respectively the volume of harvested bone marrow will 
be smaller. However, the thickness of the iliac bone at the 
perforation site, in an adult rabbit, ranges between 4.3 and 
4.8 mm (fig. 9), respectively the iliac bone can be easily 
penetrated with a 18G needle and the volume of harvested 
bone marrow may reach 4.5–5 ml, just from one side (fig. 1), 
without harming the animal’s health and exposing it to risks 
which can cost us time and money [19]. At the same time, it 
must be taken into account that the obtained volume of bone 
marrow is more than enough to obtain in a relatively short 
period of time, 12±1 days, a number of 4116667±464354.4 
cells, which is quite important.
Fig. 9.  The comparative dimensions of the iliac and femoral 
bones. Rabbit femoral and iliac bones (a). Assessment of iliac 
bone (b) and femoral bone (c) thickness.
According to literature data it is known that, in the 
bone marrow the number of MSC is very small, between 
0.01 – 0.001% of total number of bone marrow nucleated 
cells [27], or 1/10000–1/100000 according to other sources 
[28, 29, 30]. MSC can be multiplied for 500 times during 
50 generations, finally getting billions of cells [29, 30], also, 
from the 6th passage of in vitro culture, MSC lose their stem 
cells characteristics and the ability to differentiate [28, 30]. 
In other words, if we continue cultivating the obtained cells 
further in passages at a density of 8x103 cells/cm2, at the 5th 
passage we would have over 1 billion cells with differentia-
tion potential. Therefore, even 1 ml of bone marrow taken 
from a single iliac bone in rabbits, represents a sufficient vo-
lume to get a large number of MSC capable to differentiate, 
for in vitro or in vivo tests in rabbits, which is groundless 
denied and ignored in the literature [15, 10, 4, 5, 16, 17, 12].
Stem cells identifying is an important step in working 
with them. At the moment, the most common ways to iden-
tify MSC are RT–PCR, cell differentiation by adipogenic, os-
teogenic and chondrogenic pathway [2, 3], flow cytometry 
[29, 3], immunofluorescence microscopy [28, 29]. In our re-
search we identified bone marrow MSC only through chon-
drogenic differentiation pathway. Therefore, according to 
the criteria of the International Society of Cellular Therapy, 
MSC have not been fully identified, but in our opinion this 
is sufficient, because bone marrow MSC are multipotential 
cells with differentiation potential in specialized cells. How-
ever, the differentiation in chondrocytes line was confirmed 
by specific staining for cartilaginous tissue with Safranin O 
and Toluidine blue/fast green [31, 26].
Conclusions
The volume of 3.39 ± 1.27 ml of bone marrow, harvested 
from rabbit iliac bone is sufficient to obtain a large number 
of MSC for the laboratory tests in vitro and in vivo. As a 
standard method for MSC identification could be also the 
capability of the cells to differentiate in the specialized cells, 
including hondrocytes.
Disclaimer
The authors of this article did not benefit and will not be-
nefit from the goods of commercial agents or manufacturers 
by using the media purchased from them.
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